✦ LIBER ✦

Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study

✍ Scribed by Goodman, A.D.; Cohen, J.A.; Cross, A.; Vollmer, T.; Rizzo, M.; Cohen, R.; Marinucci, L.; Blight, A.R.

Book ID: 118040656
Publisher: SAGE Publications
Year: 2007
Tongue: English
Weight: 130 KB
Volume: 13
Category: Article
ISSN: 1352-4585
DOI: 10.1177/1352458506069538

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled, dose-ranging study of rosuvastatin in Japanese hypercholesterolemic subjects

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Sustained-release oral fampridine in mul

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

✍ Andrew D Goodman; Theodore R Brown; Lauren B Krupp; Randall T Schapiro; Steven R 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 166 KB

Botulinum toxin treatment of spasticity

Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study

✍ R Baker; M Jasinski; I Maciag-Tymecka; J Michalowska-Mrozek; M Bonikowski; L Car 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis

✍ Robert M. Knobler; Lars E. French; Youn Kim; Emil Bisaccia; Winfried Graninger; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 139 KB

A phase II, randomized, double-blind, pl

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

✍ Wallace, Daniel J. ;Stohl, William ;Furie, Richard A. ;Lisse, Jeffrey R. ;McKay, 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 2 views

## Abstract ## Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combination with standard of care therapy (SOC) in patients with active systemic lupus erythematosus (SLE). ## Methods Patients with a Safety of Estrogens in Lupus Erythematosus: National

Golimumab in patients with active rheuma

Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

✍ Jonathan Kay; Eric L. Matteson; Bhaskar Dasgupta; Peter Nash; Patrick Durez; Ste 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views